Name: Albemarle Corp. (NYSE:ALB) | Analysis of Revenues
Creator: Stock Analysis on Net

Analysis of Revenues

Revenues as Reported

Revenues as Reported

Albemarle Corp., income statement, revenues

US$ in thousands

12 months ended:	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Lithium	5,008,850)	1,363,284)	1,144,778)	1,358,170)	1,228,171)
Bromine	1,411,682)	1,128,343)	964,962)	1,004,216)	917,880)
Catalysts	899,572)	761,235)	797,914)	1,061,817)	1,101,554)
All Other	—)	75,095)	221,255)	165,224)	127,186)
Corporate	—)	—)	—)	—)	159)
Net sales	7,320,104)	3,327,957)	3,128,909)	3,589,427)	3,374,950)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Revenue Trends by Segment: The Lithium segment exhibited considerable variability over the analyzed period. Initial revenues increased from approximately 1.23 billion USD in 2018 to about 1.36 billion USD in 2021, showing a general upward trajectory interrupted by a dip in 2020. In 2022, Lithium revenue surged dramatically to nearly 5.01 billion USD, indicating strong growth and potentially heightened demand or market expansion in this area.; The Bromine segment demonstrated steady growth throughout the period. Revenues increased from about 918 million USD in 2018 to approximately 1.41 billion USD in 2022. This represents a consistent positive trend, with incremental gains seen each year, suggesting stable market conditions or effective business strategies supporting growth in this segment.; The Catalysts segment experienced a downward trend from 2018 to 2021. Revenue declined from roughly 1.10 billion USD in 2018 to around 761 million USD in 2021, indicating possible contraction or challenges impacting sales. However, there was some recovery in 2022, with revenues increasing to nearly 900 million USD, signaling a potential reversal of the previous decline or improvements in market conditions.; The "All Other" category showed fluctuating results, with revenues growing from approximately 127 million USD in 2018 to a peak of about 221 million USD in 2020, followed by a sharp decrease to roughly 75 million USD in 2021. Data for 2022 is missing, making trend assessment incomplete for the most recent period. This volatility could reflect either the varied nature of the products or segments included or external factors influencing this category unevenly.; Corporate revenue data is largely absent, with only a small value reported in 2018 and no data for subsequent years, thus limiting any meaningful analysis.
Total Net Sales: Net sales exhibit a pattern that largely mirrors the trends of key segments. After growing from about 3.37 billion USD in 2018 to a peak near 3.59 billion USD in 2019, net sales declined to approximately 3.13 billion USD in 2020 and partially recovered to roughly 3.33 billion USD in 2021. A significant increase occurred in 2022, with net sales more than doubling to around 7.32 billion USD. This surge is primarily driven by the dramatic increase in Lithium segment revenues.
Overall Insights: The data reveals that the company’s revenue growth in recent years is heavily influenced by the Lithium segment, particularly evident in 2022. Bromine provides steady, incremental growth, whereas Catalysts faced challenges but showed signs of recovery. The variability in "All Other" revenues and the absence of corporate data introduce some uncertainty in complete revenue performance assessment. The significant net sales increase in 2022 indicates robust business expansion or market factors favorably impacting the company’s financial outcomes.

Download chart